Steve Bloor

CEO @Videregen Limited

Leeds, GB
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2013 — Present

CEO @Videregen Limited

View department →

Videregen is a clinical-stage regenerative medicine company using its proprietary tissue engineering platform to develop a range of personalised, non-immunogenic organ and tissue replacement products for chronic and orphan indications. The platform technology, which uses decellularised organ/tissue scaffolds seeded with autologous or allogeneic cells to create new organs, has the potential to generate cost-effective and curative therapies for a range of devastating diseases. Founded in 2011, Videregen is based in Liverpool and Leeds.

SKILLS

GlpBiomedical EngineeringBiotechnologyLife SciencesV&VManufacturingLifesciencesOrthopedicProduct DevelopmentDue DiligenceR&DEntrepreneurshipGmpBiomaterialsRegulatory AffairsStart-UpsValidationRegenerative MedicineBusiness StrategyBiopharmaceuticalsFdaStrategic PlanningClinical DevelopmentTechnology TransferClinical ResearchHealthcareRisk ManagementDesign ControlClinical TrialsCapaCommercializationQuality AssuranceMedical DevicesIntellectual PropertyIso 13485Pharmaceutical IndustryProduct Launch

ABOUT STEVE BLOOR

A senior level executive with over 30 years\' experience in the medical device and…

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Steve Bloor — CEO at Videregen Limited in Leeds, GB | Unifers